Trends in Inflammatory Bowel Disease Therapy 1996

This book is the proceedings of an international symposium held in Ottawa, Ontario, Canada, June 12-15 1996, and sponsored by Axcan Pharma, the Canadian Association of Gastroenterology and the Canadian Society of Colon and Rectal Surgeons.

While the etiology and cure of inflammatory bowel disease (IBD) remain elusive, it is safe to say that there have been exciting advances in the field since the last symposium was held two years ago. A faculty of international experts from a range of disciplines - including molecular genetics, physiology, epidemiology, pediatrics, gastroenterology and surgery - was assembled and provided updates on the most current and controversial areas.

The first part of the book is devoted to a review of advances in determining the etiology of IBD with focus on mucosal inflammation and genetics. The clinical part of the book includes sessions on ileal pouches, new therapies for the treatment of Crohn’s disease, controversies related to the management of ulcerative colitis, cancer risk in IBD and management of IBD in the pediatric population.

This volume will be of interest to both gastroenterologists and colon and rectal surgeons, whether concerned with basic science or clinical practice.